Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.17	220.77	159.79
Graham Fair Price	16.33	28.23	24.27
PEG	57609.22	9.80	-0.02
Price/Book	4.08	53.47	51.38
Price/Cash Flow	1252.32	3812.48	-281.92
Prices/Earnings	20.86	76.36	63.18
Price/Sales	32.06	78.14	59.17
Price/FCF	1252.32	3812.48	-281.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.29	0.83	0.82
Operating Margin	-9.22	0.30	0.33
ROA	2.53	0.04	0.03
ROE	0.20	0.18	-13.88
ROIC	0.07	0.06	-20.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.25	-84.41
Dividends QOQ	-0.05	0.21	316.94
EBIT QOQ	5.83	-0.15	-97.45
EPS QOQ	37.21	0.08	-99.79
FCF QOQ	-0.08	1.09	1207.04
Revenue QOQ	-0.02	-0.06	-309.43
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	313.17	357.90	14.28
Days Sales Outstanding (DSO)	109.08	102.78	-5.77
Inventory Turnover	0.29	0.25	-12.50
Debt/Capitalization	0.70	0.67	-4.15
Quick Ratio	0.52	0.68	29.63
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.35	14.22	25.36
Cash	3.08	2.87	-6.90
Capex	-1.74	-1.09	37.04
Free Cash Flow	-2.07	0.20	-90.35
Revenue	9.85	9.73	-1.20
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.94	1.35	43.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.22	7.40	18.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating